Biopharmaceutical Third-Party Logistics Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the biopharmaceutical third-party logistics market?
In recent years, the biopharmaceutical third-party logistics market has witnessed robust growth. The market, valued at $141.59 billion in 2024, is expected to rise to $150.94 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.6%. The growth experienced during the historical period is a result of the globalization of pharmaceutical supply chains, rigorous regulatory standards, increasing biopharmaceuticals, and an emphasis on cold chain logistics.
What will be the biopharmaceutical third-party logistics market size in the future?
Major expansion is anticipated in the biopharmaceutical third-party logistics market in the coming years, with projections indicating a size of $203.7 billion by 2029. This signifies a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this growth during the forecast period include the rise of personalized medicine, the broadening of biologics and biosimilars, digitalization of the supply chain, increased regulatory compliance requirements, and the influence of COVID-19. Further important trends expected to shape the future include on-demand logistics services, sustainable practices in logistics, last-mile delivery solutions, pharma serialization and traceability, and autonomous logistics.
Get your biopharmaceutical third-party logistics market report here!
What main drivers are fueling expansion in the biopharmaceutical third-party logistics market?
The growth of the biopharmaceutical third-party logistics market is predicted to be fuelled by the escalating tendency to outsource logistics. This process involves hiring a third party to manage some or all of a company’s logistics operations. In the context of biopharmaceutical third-party logistics, this outsourcing typically takes the form of entrusting the management of the cryogenic supply chain to logistics partners. For example, per data from the US-based Bureau of Transportation Statistics, a division of the Department of Transportation (DOT), for-hire freight shipments saw a 1.8% uptick in December 2023 compared to the prior year. Similarly, the Freight Transportation Services Index experienced growth from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the increasing tendency to outsource logistics is forecasted to stimulate the expansion of the biopharmaceutical third-party logistics market.
What key areas define the segmentation of the global biopharmaceutical third-party logistics market?
The biopharmaceutical third-party logistics market covered in this report is segmented –
1) By Supply Chain: Cold Chain, Non-Cold Chain
2) By Service: Transportation, Warehousing And Storage, Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users
Subsegments:
1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging
2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12616&type=smp
Who are the dominant players expanding their reach in the biopharmaceutical third-party logistics market?
Major companies operating in the biopharmaceutical third-party logistics market include McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services
How are evolving market trends shaping biopharmaceutical third-party logistics Strategies?
Rising technological improvements are becoming a predominant trend within the biopharmaceutical third-party logistics sector. Dominant firms within this market are concentrating on the introduction of novel products in a bid to consolidate their standing and obtain a competitive edge. To illustrate, Celcius Logistics Solutions Pvt Ltd., a logistics service provider based in India, unveiled a Hyper-Local, temperature-controlled delivery service specialized for food and pharmaceutical orders in November 2022. This firm provides this final stage solution that is appropriate for smaller quantities and is accessible in nine Indian cities. Employing a hyperlocal strategy, the firm ensures the optimal upkeep of transported materials by ongoing real-time temperature scrutiny at every step of the delivery procedure.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12616
Which regions are emerging as leaders in the biopharmaceutical third-party logistics market?
North America was the largest region in the biopharmaceutical third party logistics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Biopharmaceuticals Contract Manufacturing Global Market Report 2024
Chemical Logistics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chemical-logistics-global-market-report
Lyophilization Services For Biopharmaceuticals Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
